GHP November 2016

18 | ghp November 2016 Innovation & Technology Vendit fulfils the obligation of responsible delivery of medical content through all channels. The software enables marketers to reach all healthcare professionals, across all mediums, with the data that underpins product claims. Vendit enables busy clinicians to consume this content when it is most relevant. Balancing regulatory compliance with the need to provide evidence is the challenge that Vendit has been built for. There are many stakeholders in the distribution chain of ethical content and it is important to engage IT functions to make them aware that Global Life Science companies don’t own commercial copyright content from publishers and that Vendit, which is a Copyright Licensing Platform (CLP), is the comprehensive answer to giving evidence from publishers to doctors. In short, doctors take responsibility for their own educational journey and make their own mind up about the scientific data behind claims. Global Life Science companies must compliantly provide that data. Vendit is the connection in this critical path and the close- knit Vendit team are passionately working to transform commercial digital distribution of copyright content. Company: Tangent 90 Ltd Name: Richard Lucas Email: [email protected] Web Address: London Info International registration link: Address: 27 Pegasus Court, Herschel Street, Slough. SL1 1PA UK Telephone: +44 1753 822 922 “In my procurement role, managing global content acquisition at GlaxoSmithKline, I was responsible for identifying a digital platform that could deliver copyrighted materials from our sales reps to doctors globally. The Vendit platform is secure, reliable, easy to use and, in my opinion, the most innovative product of its kind on the market.” - Philip Ditchfield. Vendit will be exhibited at Veeva European Commercial Summit in Madrid 29th November to 1st December 2016, with Tangent 90 as a Veeva Silver Technology partner. Vendit and lead gold partner HME will be exhibiting at London Info International (LII) on 6th-7th of December 2016 at ExCeL London.